GNAI2 Knockout Raji Polyclonal Cells provide a precisely CRISPR/Cas9-edited polyclonal population derived from the human Raji B-lymphocyte cell line, designed for functional loss-of-function studies of the GNAI2 gene. This knockout model disrupts the expression of the G protein subunit alpha i2 (G??i2), a critical transducer of Gi-coupled G protein-coupled receptor (GPCR) signals. The polyclonal nature of this edited population ensures a heterogeneous genetic background that reflects the complexity of signaling networks in B-cell research, without the clonal artifacts that may arise from single-cell-derived lines. Researchers can employ this tool to interrogate G??i2-mediated pathways in a lymphoma context, leveraging the well-characterized Raji line for reproducible experimental outcomes.
The Raji cell line, established from an Epstein-Barr virus-positive Burkitt’s lymphoma, exhibits a mature B-cell phenotype and is a cornerstone model for immunological and cancer research. Raji cells are extensively used to study B-cell receptor signaling, chemokine responses, and hematological malignancy pathogenesis. Their robust growth in suspension culture and well-documented genomic and transcriptomic profiles make them an ideal host for gene editing, facilitating consistent knockout generation and downstream phenotypic analyses. This cellular background is particularly relevant for exploring G??i2 functions given its involvement in B-cell migration, survival, and proliferation signals.
GNAI2 encodes G??i2, which mediates signal transduction from a variety of Gi-coupled GPCRs, including chemokine receptors such as CXCR4 and CCR7, lysophosphatidic acid receptors, and other upstream regulators like RGS proteins. Upon receptor activation, G??i2 inhibits adenylyl cyclase, leading to decreased intracellular cAMP levels and subsequent inactivation of protein kinase A (PKA). Concurrently, G??i2 signals through G?¦? subunits to activate phosphoinositide 3-kinase (PI3K)/AKT and mitogen-activated protein kinase (ERK) cascades, and engages Rho GTPases such as RhoA and Rac1 to regulate cytoskeletal dynamics. The G??i2 signaling hub thus integrates inputs from multiple receptors to control key cellular processes, with interacting partners including adenylyl cyclase, phosphodiesterases, and PI3K, ensuring precise modulation of downstream effectors.
In Raji cells, disruption of GNAI2 impairs Gi-mediated inhibitory signaling on adenylyl cyclase, leading to altered cAMP homeostasis and diminished activation of PI3K/AKT and MAPK/ERK pathways. This perturbation directly affects B-cell receptor and chemokine receptor functions, compromising cellular responses such as chemotaxis, proliferation, and survival. The knockout model therefore provides a physiologically relevant system to dissect the role of G??i2 in B-cell lymphoma biology, including its contribution to malignant transformation and immune evasion. The polyclonal population allows assessment of gene disruption effects across a mixed genetic background, mirroring the heterogeneity observed in patient samples and enhancing translational relevance.
This GNAI2 knockout model supports a wide range of research applications, including the investigation of G??i2-dependent signaling in B-cell lymphomas, functional dissection of chemokine receptor pathways, GPCR signaling network analysis, and drug target validation for hematological malignancies. Typical assays performed with these cells include Western blotting for G??i2 protein expression, RT-qPCR for mRNA quantification, cAMP accumulation assays, phospho-AKT and phospho-ERK immunoblotting, Transwell migration and chemotaxis assays, flow cytometry for surface receptor expression, and proliferation studies, as well as transcriptomic profiling via RNA-seq. For additional details or to arrange a discussion regarding this model, please contact Ascent Research.
